|
|
 |
|
Viewing report
|
|
|
|
Baxter International Medical Device Company Intelligence Report
Espicom Business Intelligence Ltd, Nov 2010, Pages: 48
Baxter International Inc develops, manufactures and markets products for the treatment of haemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. The company applies a combination of expertise in medical devices, pharmaceuticals and biotechnology and operates in three segments:
Medication Delivery – manufactures intravenous (IV) solutions and administration sets, pre-mixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps and inhalation anaesthetics, as well as products and services related to pharmacy compounding, drug formulation and packaging technologies.
Renal – provides products to treat end-stage renal disease, or irreversible kidney failure. The business manufactures solutions and other products for peritoneal dialysis (PD), a home-based therapy, and also distributes products for haemodialysis (HD), which is generally conducted in a hospital or clinic. This business segment was expanded in September 2009 with the acquisition of certain assets relating to Edwards Lifesciences’ continuous renal replacement therapy (CRRT) product line.
BioScience – processes recombinant and plasma-based proteins to treat haemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products; and vaccines. In March 2010, Baxter acquired ApaTech, which provided Baxter with immediate entry into the emerging bone fusion field.
This profile primarily concentrates on Baxter’s medical device activities.
Baxter has approximately 49,700 employees and conducts business in over 100 countries. In 2009, the company reported revenues of US$12.56 billion, of which approximately 58% were generated outside of the US. Baxter maintains manufacturing and distribution facilities in a number of locations in the US, Europe, Canada, Asia-Pacific and Latin America.
This company report provides:
Overview:
- Key contact information
- Introduction to the company and its current activities
- Summary of its financial performance
- Who are the company’s major competitors?
- Key recent events in an “at a glance” format
Financial Review:
- Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
- Table providing in-depth five-year financial analysis
- Employee data, including breakdown by company division and geographic location
Strategic Focus:
- Investigates the company’s aims and its areas of focus
Products:
- Core product areas, key brands, product approvals and launches Research and Development
- How much has been invested in R&D?
- Where is the research based?
- What alliances and agreements does the company have and with whom?
Manufacturing and Distribution:
- Identifying the company’s manufacturing locations
- Sales and marketing facilities
Agreements:
- With whom has the company reached agreements and what do they involve?
- Key contracts awarded
Mergers, Acquisitions, Minority Investments and Divestments
Litigation
Key Corporate Events
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Renal Dialysis Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
End-Stage Renal Disease (ESRD) Dialysis Devices & Services Worldwide
Global and Chinese Hemodialysis Industry Report, 2011-2012
Global and Chinese Hemodialysis Industry Report, 2011-2012
Kidney Dialysis Equipment and Supplies - Global Strategic Business Report
Renal Dialysis Equipment Market to 2017- Lower Costs and Similar Efficacy Rates as Hemodialysis to Increase Adoption Rates of Peritoneal Dialysis
Renal Dialysis Services - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017
Renal Dialysis Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Gambro Medical Device Company Intelligence Report
Artificial Organs - Global Strategic Business Report
|
|
|
|
